Domov › Akutna mieločna levkemija › Arizona › Tucson

Klinične študije za Akutna mieločna levkemija v Tucson, AZ

9 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Tucson in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3

The University of Arizona Cancer Center, Tucson

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3

Banner University Medical Center - Tucson, Tucson

6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2

Banner University Medical Center - Tucson, Tucson

Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija

University of Arizona Medical Center - Tucson, Tucson

Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v Tucson

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.